Keywords spatial sequencing protein-protein interactions protein complexes proximity ligation assay multi-modal germinal center tonsil B cell cell-cell communication multi-omics Get full text access Log in, subscribe or purchase for full access. References 1. Chen, K.H. ∙ Boettiger, A.N. ∙ Moffitt, J.R. ... RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells Science. 2015; 348, aaa6090 2. Yao, Z. ∙ van Velthoven, C.T.J. ∙ Kunst, M. ...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Marcus Clark
Shaping drug development with tumor organoids and RWD
Learn how Tempus AI's noninvasive imaging techniques allow for the continuous study of the same organoids across various assays, preserving their viability for longitudinal analysis and multiplexed testing.
World Clinical Biomarkers & CDx Summit 2024
Exhibit Booth #4 Plenary Session Schedule a meeting with us Plenary Session September 4, 2024 live session Time 3:10pm-3:40pm ET Location The Westin Boston Seaport District 425 Summer Street Boston, MA 02210 Presenter Alain Silk Sr. Director, Regulatory Affairs (Tempus) Explore the latest in diagnostic development as we delve into evolving regulatory landscapes and pre-market pathways. Learn how novel biomarkers and AI-driven algorithms are shaping the future of Companion Diagnostics (CDx).
NSGC Annual Conference 2024
Booth #227 Evening Reception Schedule a meeting with us Thank you for your interest in our event at NSGC. The event has concluded, and we are no longer accepting RSVP submissions. To explore more about Tempus and to keep the conversation going, please take a moment to share a bit more about what you are interested in. We will connect you with the right team member. Schedule a meeting with us We'll be in touch shortly. Thank you for contacting Tempus. We will respond shortly.
Using an AI algorithm to predict possible MSI high status in prostate cancer patients from digital pathology images
Tissue sequencing in prostate cancer is often challenging because of limitations of tumor quantity or tissue quality; bone metastases are frequent. It is critical to identify whether patients are MSI-H since they may be eligible for immunotherapy and/or may need workup for Lynch syndrome.
ASCO® Annual Meeting 2024
Experience live demos of our newest technologies for providers, biopharma, and research partners. Stop by our booth to discover how we are leveraging AI and technology to advance precision oncology. Tempus One: Interact with our AI-enabled clinical assistant that simplifies access to patient insights. Just ask a question and receive real-time, data-driven answers to inform treatment decisions.
Personalized depression treatment with pharmacogenomic testing
Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Marcus
Contact Marcus, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack